Deepcell co-founder Maddison Masaeli took an unexpected path from academic research to launching an AI-powered cell analysis platform. The company has raised close to $100 million in funding to support its mission. This includes a $73 million Series B round and an earlier $20 million Series A round. The company has entered into a research…

Messenger RNA (mRNA) therapeutics and vaccines may offer significant promise, but few scientists specialize in the technology. Moderna (NSDQ: MRNA) aims to inspire a new generation of scientists and clinicians to focus on mRNA research with a new fellowship program. The program will support a range of applications within medicine, basic research, epidemiology, pharmacology, nursing…